Combining Proteograph technology with Zeno SWATH DIA acquisition enables the potential for deep, unbiased discovery of biomarkers in blood - Pushing the Boundaries in Proteomics | Seer Inc.
Last Updated
24 June 2022
Combining Proteograph technology with Zeno SWATH DIA acquisition enables the potential for deep, unbiased discovery of biomarkers in blood
